Nuo Therapeutics modifies warrant exercise price; all warrants exercised for 6.87M shares and $1.37M

Nuo Therapeutics, Inc.

Warrant exercise price reduced from $0.40 to $0.20 per share, with exercise required by Jan 31, 2022.
All 6,865,461 warrants exercised by Dec 30, 2021, raising $1,373,092 in gross proceeds.
Company issued 6.87M shares of common stock in exempt private placement under Section 4(a)(2) and 3(a)(9).
Warrants were originally issued in October 2020 recapitalization and for services to executives including CEO David Jorden.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.